Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis
Authors
Keywords
CD133, Nestin, Prognosis, Glioma
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 34, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-05-14
DOI
10.1186/s13046-015-0163-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets
- (2014) Alessandro Allegra et al. CANCER INVESTIGATION
- The Evolving Role of Molecular Markers in the Diagnosis and Management of Diffuse Glioma
- (2014) J. T. Huse et al. CLINICAL CANCER RESEARCH
- The multiple facets of drug resistance: one history, different approaches
- (2014) Evandro Niero et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II–III astrocytomas and oligoastrocytomas
- (2014) Kimmo J. Hatanpaa et al. JOURNAL OF NEURO-ONCOLOGY
- Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysate-pulsed dendritic cells
- (2014) Ming Xu et al. JOURNAL OF NEURO-ONCOLOGY
- Cell surface Nestin is a biomarker for glioma stem cells
- (2013) Xiong Jin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach
- (2013) Federica Tomao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas
- (2013) Jung Ha Shin et al. JOURNAL OF NEURO-ONCOLOGY
- The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence
- (2013) Ichiyo Shibahara et al. NEURO-ONCOLOGY
- Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme
- (2013) Marju Kase et al. Radiology and Oncology
- Nestin Expression Identifies Ependymoma Patients with Poor Outcome
- (2012) Till Milde et al. BRAIN PATHOLOGY
- Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomas
- (2012) Hideo Arai et al. Brain Tumor Pathology
- MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
- (2012) Consolación Melguizo et al. Journal of Translational Medicine
- Prognostic Impact of CD133 mRNA Expression in 48 Glioblastoma Patients Treated with Concomitant Radiochemotherapy: A Prospective Patient Cohort at a Single Institution
- (2011) Philippe Metellus et al. ANNALS OF SURGICAL ONCOLOGY
- Association of Stem Cell-Related Markers and Survival in Astrocytic Gliomas
- (2011) Feng Wan et al. BIOMARKERS
- The different HMGA1 expression of total population of glioblastoma cell line U251 and glioma stem cells isolated from U251
- (2011) Haitao Fan et al. BRAIN RESEARCH
- The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas
- (2011) Kyung-Jung Kim et al. NEUROPATHOLOGY
- CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids
- (2011) Seyed Ardebili et al. Radiology and Oncology
- High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) R. Stupp et al. ANNALS OF ONCOLOGY
- Insight into the complex regulation of CD133 in glioma
- (2010) Benito Campos et al. INTERNATIONAL JOURNAL OF CANCER
- Immunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study
- (2008) Motohiro Kojima et al. CANCER SCIENCE
- Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
- (2008) F. Zeppernick et al. CLINICAL CANCER RESEARCH
- Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
- (2008) Mingyu Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Expression of CD133-1 and CD133-2 in ovarian cancer
- (2007) G. FERRANDINA et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now